Marine organisms, in particular nudibranchs (Mollusca: nudibranchia), are known as a rich source of chemically diverse secondary metabolites exhibiting potential as antimalarial, antiinflammatory, antiviral and anticancer activity. We presented the chemical investigation of an extract of nudibranch Hypselodoris infucata collected from Bali, an unexplored water but rich in nudibranch diversity. The extract contained the known (-)-furodysinin (1), a furanosesquiterpene that for the first time isolated from this species. Metabolite 1 was purified by chromatography and the structure was characterised by comparison of 1 H NMR data with that of the reported data. The absolute configuration was determined by comparing the optical rotation values with the known enantiomer. In vitro cytotoxic activity of compound 1 against HeLa cell line displayed an IC50 at 102.7µg/mL. We also report for the first time the development of a method to assay nudibranch extracts for their feeding deterrence activity against local shrimps Penaeus vannamei. The extract show food rejection with highly significant difference in respect to the control (P = 0.0061) at natural concentration of 3.0mg/mL.
INTRODUCTION
Secondary metabolites play an important role as a starting point in the drug discovery process. Marine organisms offer an abundant source of chemically diverse and biologically active secondary metabolites. Among marine organisms, sponges and nudibranchs are prolific sources of diverse natural products, and the study of their chemical properties has led to the discovery of many biologically potent chemicals with antimalarial, anti-inflammatory, antiviral and anticancer activity (Blunt et al., 2015) .
Nudibranchs (Mollusca: nudibranchia) are slow-moving marine molluscs with soft bodies and often present bright and attractive coloration. However, despite slow movements and the absence of physical attributes, only few predators have been documented. Chemoecological studies showed that nudibranchs may employ secondary metabolites as chemical defence mechanism against predators (Cimino and Ghiselin, 2009; Mudianta et al., 2014) . The metabolites are either derived from their diets mainly sponges or biosynthesized in de novo fashion (Fontana et al., 2012) . This spongeprey relationship has resulted an array of metabolites with intriguing framework, which are not found in their terrestrial counterparts and showed the potential as new pharmaceutical agents (Gerwick and Moore, 2012) .
Furanosesquiterpenoids are the most dominant metabolites characterised from nudibranchs of the genus Hypselodoris (Gastropoda: nudibranchia) and they seem to be a specific chemotaxonomic marker in these organisms (Fontana et al., 2001) . Additionally, some species within this genus have also been reported to produce diterpenoids (Hochlowski et al., 1982) as well as sesterpenoids (Cimino et al., 1993) . There have been 17 different species of Hypselodoris chemically investigated and reported from 1982 until 2012. The animals were collected from disparate geographical regions including California (USA), Brazil (Latin America), the Mediterranean (Europe), South Africa, and India.
Here we presented an initial chemical investigation of nudibranch Hypselodoris infucata collected from Tulamben-Bali, a less-explored waters but rich in species diversity. Our research group have pioneered the chemical investigation of marine invertebrate mainly sponges and nudibranchs from this prolific site (Mańdi et al., 2015; Mudianta et al., 2014) . We also reported for the first time the development of a method to assay nudibranch extracts for their feeding deterrent activity against local shrimps Penaeus vannamei.
MATERIAL AND METHIODS

Materials
Two specimens of Hypselodoris infucata (crawling length 2cm) were collected during fieldwork at Tulamben Bay, Bali in November 2014. The specimens were identified by comparing the surface pictures with that in the encyclopaedia of nudibranch as well as with the online database such as nudipixel (www.nudipixel.net) and WoRM (www.marinespecies.org). The first specimen (coded by the authors as 28-11-14-12) was extracted for chemical study, while the second specimen (coded as 28-11-14-13) was employed in the feeding assay.
Procedure
Extraction and isolation of metabolite
A single specimen of Hypselodoris infucata (Figure 1 ) was diced, extracted in acetone (3x10mL), and sonicated for 2min. The combined extracts were partitioned between water and dichloromethane (3x5mL) and subsequently the organic layer was dried with Na2SO4. Dried organic layer was evaporated to dryness to give a crude extract (5mg). The extract was passed through a normal-phase Sep-Pak cartridge eluting with 100% hexane (10mL) to provide compound 1 (1.3mg).
General 1 H NMR data were recorded using Bruker Advance 500MHz spectrometers (5mm inverse probe, gradient selection). Measurements were made in deuterochloroform (CDCl3, referenced at: δH 7.26ppm, δC 77.16ppm). Chemical shifts (δ) were recorded in parts per million (ppm) and coupling constants (J values) were measured in Hertz (Hz). Positive ion electrospray mass spectra were determined using a Bruker Esquire HCT instrument (LRESIMS) with MeOH as solvent. Infra-red spectrum was recorded on a PerkinElmer FT-IR/FIR spectrometer. Specific optical rotations were measured at the sodium D line (589nm) at ambient temperature using a 1mL quartz cell with a 10cm path length, using a Jasco P-2000 polarimeter. TLC investigations were performed on TLC silica gel 60G F254 (Merck). Solvents were distilled prior to use. GC/MS analyses were performed on a Shimadzu GCMS QP-2010 Plus gas chromatograph mass spectrometer, operating at 70eV, fitted with a DB-5 column (30m, internal diameter 0.25mm, J&W Scientific). Standard GCMS programme: split mode; column flow 1.5mL/min; initial oven temperature 100°C (isothermal for 3min), ramp 16°C/min to 250°C held for 10min; injection temperature 250°C (total programme time 30min). Samples for GC/MS were prepared in HPLC grade nhexane (1mg/mL).
Anticancer assay
In vitro anticancer assay of compound 1 against HeLa tumor cell line was performed by colorimetric assay using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium bromide (MTT) (Hughes and Mehmet, 2003) . The HeLa cervical cancer cell lines were cultured in RPMI 1640 medium containing 10% Fetal Bovine Serum (FBS), 0.5% fungizone and 2% Penicillin-Streptomycin. The HeLa cells were plated at 10,000 cells per well and incubated at 37°C with 5% of CO2 flow for 24h. After that, tested compound and doxorubicin as positive control were tested in a single concentration of 30µg/mL (dissolved in RPMI medium) for 24h. Each sample was tested in three replicates. The cell-growth medium was removed from each well before the extracts were plated into the wells containing HeLa cells attached. Three kinds of controls were made, i.e. control of tumor cells, control of medium (medium without tumor cells) and control of samples (samples without tumor cells). After 24h treatment of the tested compound, the solution was removed from each well. After that, 100µL of MTT reagent (500μg/mL) was added into each wells and incubated for 4h in CO2 incubator until purple precipitate was visible.
As much as 100µL of sodium dodecyl sulphate (SDS) 10% was added into each well, and incubated at room temperature (±27°C) in the dark for 12h. After incubation, the absorbance of each well was measured by DYNEX microplate reader at wavelength of 570nm. The percentage of cell death was calculated using the formula:
Description: A = absorbance of tumor cell control, B = absorbance of the sample, C = absorbance of sample control, D = absorbance of medium control.
The anticancer activity against HeLa was then tested in serial concentration of 12.5, 25, 50, and 75μg/mL. The Inhibition Concentration 50 (IC50) value was then calculated using MINITAB 16.0 probit analysis.
Feeding Deterrence Assay
The second specimen of Hypselodoris infucata (coded as 28-11-14-13) was extracted in the same manner as the first one to give 6 mg crude extract. The feeding assay was carried out according to protocol reported by Mollo et al. (2008) (Mollo et al., 2008) . In this assay we employed local shrimps Penaeus vannamei instead of the marine generalist shrimp The replacement of the shrimp species in Mollo's protocol was due to the availability of the shrimps in the local area in Bali. The rest of the protocol was performed exactly as described by Mollo et al. (2008) . The crude nudibranch extract (1mg) was dissolved in 0.5mL of acetone was added to a mixture composed of alginic acid (30mg), ground freeze-dried squid mantle (50mg), and purified sea sand (3 mg; granular size 0.1-0.3mm). Sand was included in the mixture to prevent the floating of the pellets on the surface of the water during the experiments. After evaporation of the solvent, one drop of food coloring and distilled water was added to 1-mL volume. Food coloring was added for an easy detection of the ingested food in the digestive tube of the shrimps. The mixture was stirred, loaded into a 5mL syringe, and extruded into a 0.25M calcium chloride solution for 2min to harden (Figure 2a) . The resulting spaghetti-like red strand was cut into 10-mm-long pellets (Figure 2b ). Control foods were made in the same manner, with the addition of 0.5mL of acetone but without the purified metabolites. Shrimps (average size 30mm), obtained from shrimp breeding site in North Bali, and were kept in an aquarium for 1 week to get them accustomed to the daily proposed artificial food. After 3 days of total fasting, they were individually placed in 500mL beakers filled with 300mL of sea water (Figure 2c ). Control or treated pellets were presented to shrimps in series of 10 independent replicates. After 30min, the presence of an evident red spot in the digestive tube of the shrimps was assumed as proof of acceptance and, conversely, its absence was the sign of a rejection response (Figure 2d ). The significance of differences in the consumption of treated vs. control pellets were evaluated by two-tailed Fisher's exact test. P values <0.05 were considered statistically significant.
RESULTS AND DISCUSSION
The chemistry of Hypselodoris infucata
Compound 1 (1.3mg) was isolated as a colorless oil ([α]D -51) and showed a single GCMS peak at m/z 216 (M + ) with a strong diagnostic base peak at m/z 122 (C8H8O) arising from a retro Diels-Alder reaction of the carbocyclic ring adjacent to the furan ring (Dunlop et al., 1982) . The 1 H NMR (CDCl3, 500MHz) spectrum of 1 revealed the presence of diagnostic furan protons at δH 7.21 (1H, d, J = 1.7Hz, H-1) and δH 6.23 (1H, d, J = 1.7Hz, H-2) together with an olefinic proton at δH 5.61 (1H, brs, H-10). There were also two geminal methyl groups resonated at δH 1.19 (3H, s, H-15) and δH 1.18 (3H, s, H-14) along with a methyl attached to an on olefinic carbon at δH 1.66 (3H, s, H-13). These 1 H NMR data of 1 were in close agreement with those of the synthetic sample of furodysinin reported by Vaillancourt et al. in 1991 (Figure 3 ) (Vaillancourt et al., 1991) . (Vaillancourt et al., 1991) . Recently, (-)-(6R,11R)-furodysinin (1) has been isolated from D. herbacea (Fiji) (Horton et al., 1990) , from H. bayeri collected from Cuba (Fontana et al., 1994) , and from H. jacksoni from South-East Queeensland, Australia. (-)-Furodysinin isolated from H. infucata in the current study has consistently been associated with a 6R, 11R configuration, whereas the positive counterpart shows a 6S, 11S configuration (Table I) In vitro anticancer assay of (-)-furodysinin (1) determined by MTT method displayed inhibition at IC50 at 102.7µg/mL which was less potent compared to the positive control doxorubicin that showed a value of 2.3µg/mL. This result strongly suggested to explore other bioassay target for compound 1 including antibiotic as some furanosesquiterpene metabolites were reported to show promising bioactivity (Richou et al., 1989) . The bioactivity of compound 1 has never been reported, however related derivative such as acetylthioxy-furodysinin lactone, a bioactive component of the marine sponge Dysidea, was reported to show as a potent LTB4 receptor partial agonist (Carte' et al., 1989) .
Feeding deterrence profile of the extract of Hypselodoris infucata
The feeding deterrence assay of the extract of H. infucata was carried out by following a protocol that was first reported by Mollo et al. (2008) except for the use of shrimps Penaeus vannamei instead of Palaemon elegans (Mollo et al., 2008) . Mollo employed the assay to assess palatability of brominated (Guella et al, 1985) Mediterranean -54 R R Synthetic (Vaillancourt et al, 1991 ) --61 R R D. herbacea (Horton et al, 1990 ) Fiji -55 R R H. bayeri (Fontana et al, 1994 tetrahydropyran isolated from Hypselodoris cyanomarginata against the generalist shrimp P. elegans collected at the Mediterranean seas. The brominated metabolites at its natural volumetric concentration found to show a 2.3 mg/mL food rejection with a highly significant difference in respect to the control (P = 0.0001). da Cruz (2012) replicated the feeding deterrence assay assay toxicity in a nudibranchsponge predator-prey association obtained at Portuguese coast (da Cruz et al., 2012) . Palatability tests of the crude extract of the sponge Dysidea fragilis and the nudibranch Hypselodoris cantabrica revealed a more effective deterrence in the nudibranch extracts because significant rejection rates were observed at lower concentrations than those necessary for the sponge extracts to have the same effect.
The extract (Figure 4 ) show food rejection with highly significant difference in respect to the control (P = 0.0061) at natural concentration of 3.0mg/mL. This value is considered to be identical with that found by Mollo and presented additional palatability data of the Hypselodoris nudibranch. Ten Penaeus vannamei specimens were randomly chosen for each test (n = 10). The significance of differences in the consumption of treated vs. control pellets were evaluated by two-tailed Fisher's exact test. P values <0.05 were considered statistically significant.
CONCLUSION
Chemical investigation of the extract of Balinese nudibranch Hypselodoris infucata yielded the known (-)-furodysinin (1). The metabolite was for the first time reported from this species and exemplified additional furanosesquiterpene metabolite isolated from the nudibranch. In vitro cytotoxic activity of compound 1 against HeLa cell line displayed an IC50 at 102.7 µg/mL. We also succeeded in replicating the feeding deterrence assay of the extract of H. infucata using local shrimps Penaeus vannamei.
